---
figid: PMC11626976__DDDT-18-5615-g0004
figtitle: Interaction role between TRIM family and STAT3 signaling pathway in GI cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11626976
filename: DDDT-18-5615-g0004.jpg
figlink: /pmc/articles/PMC11626976/figure/F4/
number: F4
caption: The interaction role between TRIM family and STAT3 signaling pathway in GI
  cancer. Growth factors and cytokines engage transmembrane receptors, initiating
  receptor-associated JAK activation. This prompts phosphorylation of receptor cytoplasmic
  tails, recruiting and phosphorylating cytoplasmic STAT3. Activated STAT3 forms dimers,
  transfers to nucleus, and induce target gene expression. TRIMs (eg, TRIM14, TRIM27,
  TRIM29, TRIM52, TRIM66) modulate JAK/STAT signaling. TRIM29 and TRIM66 activate
  JAK2/STAT3, while TRIM27 activates JAK1/STAT3. TRIM52 promotes SHP2 polyubiquitination
  and degradation, thereby enhancing STAT3 phosphorylation
papertitle: Exploring the Mechanisms, Biomarkers, and Therapeutic Targets of TRIM
  Family in Gastrointestinal Cancer
reftext: Chunyan Weng, et al. Drug Des Devel Ther. 2024;18(NA).
year: '2024'
doi: 10.2147/DDDT.S482340
journal_title: Drug Design, Development and Therapy
journal_nlm_ta: Drug Des Devel Ther
publisher_name: Dove Press
keywords: tripartite motif | E3 ubiquitin ligase | ubiquitinâ€“proteasome system | GI
  cancer | molecular pathways
automl_pathway: 0.9627666
figid_alias: PMC11626976__F4
figtype: Figure
redirect_from: /figures/PMC11626976__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11626976__DDDT-18-5615-g0004.html
  '@type': Dataset
  description: The interaction role between TRIM family and STAT3 signaling pathway
    in GI cancer. Growth factors and cytokines engage transmembrane receptors, initiating
    receptor-associated JAK activation. This prompts phosphorylation of receptor cytoplasmic
    tails, recruiting and phosphorylating cytoplasmic STAT3. Activated STAT3 forms
    dimers, transfers to nucleus, and induce target gene expression. TRIMs (eg, TRIM14,
    TRIM27, TRIM29, TRIM52, TRIM66) modulate JAK/STAT signaling. TRIM29 and TRIM66
    activate JAK2/STAT3, while TRIM27 activates JAK1/STAT3. TRIM52 promotes SHP2 polyubiquitination
    and degradation, thereby enhancing STAT3 phosphorylation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MBTPS1
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - TRIM29
  - TRIM27
  - TRIM66
  - TRIM14
  - STAT3
  - PTPN11
  - TRIM52
  - SPHK1
  - MMP2
  - MMP9
  - S1P
---
